Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMoneysupermarket.Com Regulatory News (MONY)

Share Price Information for Moneysupermarket.Com (MONY)

Share Price is delayed by 15 minutes
Get Live Data
182.20    1.60 (0.89%)
Bid:
181.90
Ask:
182.10
Spread: 0.20 (0.11%)
Market Cap: £942.79m
MONY Live PriceLast checked at - London Stock Exchange

Intraday Moneysupermarket.Com Share Chart

Q3 Trading Statement

17 Oct 2019 07:00

RNS Number : 1428Q
Moneysupermarket.com Group PLC
17 October 2019
 

17 October 2019

Q3 2019 Update: Revenue grows 4% as energy outperforms

Moneysupermarket.com Group PLC reports trading results for the quarter ended 30 September 2019

 

 

3 months to

30 September 2019

9 months to

30 September 2019

 

£m

Growth %

£m

Growth %

Insurance

49.9

3

146.0

3

Money

20.6

(5)

67.2

1

Home services

17.7

21

51.9

40

Other revenue*

12.7

10

35.1

41

Total

100.9

4

300.2

11

*Other revenue in Q3 includes £6.6m attributable to Decision Technologies which was acquired 9 August 2018

 

§ Insurance grew in a subdued premium environment despite some volatility in our natural search rankings

 

§ Money underperformed due to the continuing challenges in product availability

 

§ Energy switching remained strong due to the great provider offers and large customer savings

 

 

Mark Lewis, CEO of Moneysupermarket Group, said:

"The group continued to grow in the quarter, with strong trading in energy showing that there are still big savings to be made by customers even though the price cap is lower. 

"Even better, our Reinvent strategy continues to do more for our customers - the new MoneySuperMarket Energy Monitor service means our customers need never overpay for energy ever again."

 

Outlook:

We expect the overall trading dynamics to continue to the end of the year and within that Money to weaken. The Board remains confident of meeting current market expectations for the full year.

 

For further information, contact:

Scilla Grimble Chief Financial Officer Scilla.Grimble@moneysupermarket.com / 0207 379 5151

Jo Britten Investor Relations Director Jo.Britten@moneysupermarket.com / 0789 646 9380

William Clutterbuck Maitland AMO wclutterbuck@maitland.co.uk / 0207 379 5151

 

Notes:

Adjusted EBITDA is operating profit adjusted for depreciation, amortisation and other non-underlying costs including strategy related costs.

Market expectations for the 12 months to 31 December 2019 (from the analyst consensus on our investor website) are in a range of £138.1m to £144.6m, with an average of £141.9m.

 

 

This statement may include statements that are forward looking in nature. Forward looking statements involve known and unknown risks, assumptions, uncertainties and other factors which may cause the actual results, performance or achievements of the Group to be materially different from any future results, performance or achievements expressed or implied by such forward looking statements. Except as required by the Listing Rules and applicable law, the Group undertakes no obligation to update, revise or change any forward-looking statements to reflect events or developments occurring after the date such statements are published. The information in this release is based on management information.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTMFBFTMBTBBRL
Date   Source Headline
18th Apr 20237:00 amRNS1st Quarter Results
11th Apr 20234:42 pmRNSDirector/PDMR Shareholding
3rd Apr 20232:09 pmRNSDirector/PDMR Shareholding
3rd Apr 20239:20 amRNSDirector/PDMR Shareholding
31st Mar 20234:30 pmRNSTotal Voting Rights
7th Mar 202312:08 pmRNSDirector/PDMR Shareholding
2nd Mar 20237:00 amRNSAnnual Financial Report and Notice of AGM
28th Feb 20234:30 pmRNSTotal Voting Rights
16th Feb 20237:00 amRNSPreliminary Results
9th Feb 20233:42 pmRNSDirector/PDMR Shareholding
1st Feb 20234:36 pmRNSBlock listing Interim Review
31st Jan 20234:30 pmRNSTotal Voting Rights
18th Jan 202310:00 amRNSDirectorate Change
10th Jan 202310:40 amRNSDirector/PDMR Shareholding
30th Dec 202211:52 amRNSTotal Voting Rights
8th Dec 202211:29 amRNSDirector/PDMR Shareholding
30th Nov 20224:30 pmRNSTotal Voting Rights
8th Nov 20223:11 pmRNSDirector/PDMR Shareholding
3rd Nov 20223:44 pmRNSDirector/PDMR Shareholding
31st Oct 20224:30 pmRNSTotal Voting Rights
26th Oct 202211:16 amRNSHolding(s) in Company
21st Oct 20227:00 amRNSChief Financial Officer Appointment Date
18th Oct 20227:00 amRNSQ3 Trading Statement
10th Oct 20229:18 amRNSDirector/PDMR Shareholding
30th Sep 20224:30 pmRNSTotal Voting Rights
28th Sep 20222:01 pmRNSDirector/PDMR Shareholding
27th Sep 20221:38 pmRNSDirector/PDMR Shareholding
26th Sep 20227:00 amRNSDirectorate Changes - Appointment of CFO & NED
22nd Sep 20229:19 amRNSHolding(s) in Company
31st Aug 20224:30 pmRNSTotal Voting Rights
22nd Aug 20227:00 amRNSHolding(s) in Company
1st Aug 20229:00 amRNSBlock listing Interim Review
29th Jul 20224:00 pmRNSTotal Voting Rights
21st Jul 20227:00 amRNSInterim Results
6th Jul 20222:11 pmRNSHolding(s) in Company
1st Jul 20229:42 amRNSTotal Voting Rights
22nd Jun 20229:35 amRNSHolding(s) in Company
20th Jun 20227:00 amRNSDirectorate Change
13th Jun 20224:05 pmRNSHolding(s) in Company
1st Jun 20228:32 amRNSTotal Voting Rights
27th May 20224:50 pmRNSHolding(s) in Company
26th May 202211:36 amRNSDirectorate Change
17th May 20224:38 pmRNSHolding(s) in Company
10th May 20229:40 amRNSHolding(s) in Company
9th May 20227:00 amRNSDirector/PDMR Shareholding
5th May 20223:02 pmRNSResult of AGM
3rd May 202210:43 amRNSTotal Voting Rights
26th Apr 20222:45 pmRNSHolding(s) in Company
14th Apr 20229:51 amRNSHolding(s) in Company
14th Apr 20229:47 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.